GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company. GSK will acquire those shares …

Cambridge, UK-based drug discovery and development company Cellzome has appointed Alan Watt to its senior management team as vice president …
GlaxoSmithKline has formed a second strategic alliance with Cellzome to research new treatments for inflammatory diseases. GSK will buy into …

